subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: Immunosuppression


subject: PUBCHEM.COMPOUND:6917964

object_name: Decreased Immunologic Activity [PE]

tested_intervention: unsure


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: precancerous condition


subject: UNII:BPQ010OFD7

subject_name: RALUDOTATUG DERUXTECAN

object_name: non-small cell lung carcinoma


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a


subject: UMLS:C5854467

subject_name: Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978

object_name: rheumatoid arthritis

tested_intervention: yes


subject: UNII:PFP09575EX

object_name: No Evidence of Disease


subject: PUBCHEM.COMPOUND:54201037

subject_name: Retinoid 9CUAB30


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Disorder of intraocular pressure


subject: CHEBI:41879

object_name: Intraocular Pressure


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Blood Pressure Finding


subject: UNII:19FUJ2C58T

object_name: Systemic arterial pressure


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C3531686


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: Post-ERCP acute pancreatitis


subject: UMLS:C0205953

subject_name: Stilamin


subject: CHEBI:41879

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:41879

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:41879

object_name: Rectal cancer stage IV


subject: CHEBI:41879

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:41879

object_name: Recurrent Rectal Cancer


subject: CHEBI:41879

object_name: colon adenocarcinoma


subject: CHEBI:41879

object_name: Colon cancer recurrent


subject: CHEBI:41879

object_name: rectum adenocarcinoma


subject: CHEBI:41879

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:41879

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:41879

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:3441

subject_name: Carvedilol

object_name: cancer


subject: CHEBI:3441

object_name: neoplasm


subject: PUBCHEM.COMPOUND:54681072

subject_name: Omadacycline

object_name: Diabetic foot infection


subject: UNII:090IP5RV8F


subject: UMLS:C2726835

subject_name: FentaNYL Matrix

object_name: lung cancer


subject: UMLS:C2726835

object_name: lung neoplasm


subject: UMLS:C2726835

object_name: lung carcinoma


subject: CHEBI:74224

object_name: non-small cell lung carcinoma


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:28088

subject_name: Genistein


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:135405876

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:135405876

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:135405876

object_name: Depression, CTCAE


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: MESH:D013662

subject_name: Tea

object_name: prostate carcinoma


subject: MESH:D013662

object_name: prostate cancer


subject: CHEBI:28621

subject_name: Trolamine


subject: CHEBI:28621


subject: CHEBI:35026

subject_name: triethylamine


subject: CHEBI:35026


subject: PR:000015198

subject_name: cationic amino acid transporter 2


subject: PR:000015198


subject: UMLS:C4732941

subject_name: Fibrocaps

object_name: Postoperative Hemorrhage, CTCAE


subject: UMLS:C4732941

object_name: Postoperative Hemorrhage


subject: UMLS:C0016004

subject_name: Beriplast P


subject: UMLS:C0016004


subject: UMLS:C5235281

subject_name: ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005

object_name: KRAS mutation-related tumors


subject: CHEBI:229220

subject_name: Repotrectinib


subject: CHEBI:3175

subject_name: Brimonidine

object_name: rosacea


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: skin squamous cell carcinoma


subject: UMLS:C0013227

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C5418018

subject_name: SIRPa-Fc-CD40L Fusion Protein SL-172154


subject: UMLS:C5418018


subject: UMLS:C5418018

object_name: head and neck squamous cell carcinoma


subject: CHEBI:75984

subject_name: Flecainide

object_name: atrial septal defect, ostium secundum type


subject: CHEBI:75984

object_name: patent foramen ovale


subject: CHEBI:75984

object_name: Cryptogenic Ischemic Stroke


subject: CHEBI:75984

object_name: Atrial arrhythmia


subject: GTOPDB:13936

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:13936

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:H2976538CX

subject_name: Dapaconazole

object_name: tinea pedis


subject: CHEBI:191852

subject_name: Ergmt

object_name: multiple sclerosis


subject: CHEBI:191852

object_name: Inflammation


subject: CHEBI:191852

object_name: Guillain-Barre syndrome


subject: CHEBI:191852

object_name: Guillain-Barre Syndrome, CTCAE


subject: UMLS:C0009392

subject_name: Colony-Stimulating Factors


subject: UMLS:C0009392


subject: UMLS:C0009392


subject: UMLS:C0009392


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376561

subject_name: Recombinant Colony-Stimulating Factors


subject: UMLS:C0376561


subject: UMLS:C0376561


subject: UMLS:C0376561


subject: CHEBI:8499

subject_name: Propranolol

object_name: Metastatic urothelial carcinoma


subject: CHEBI:8499

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:8499

object_name: Urothelial carcinoma ureter metastatic


subject: CHEBI:8499

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:8499

object_name: Metastatic Urethral Urothelial Carcinoma


subject: CHEBI:8499

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: CHEBI:8499

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: CHEBI:8499

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: CHEBI:8499

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: CHEBI:8499

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: CHEBI:8499

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:8499

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: CHEBI:8499

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:8499

object_name: Stage IV Ureter Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3021749

object_name: Dyspnea


subject: PUBCHEM.COMPOUND:3021749

object_name: Dyspnea, CTCAE


subject: PUBCHEM.COMPOUND:3021749

object_name: cardiovascular surgery result: dyspnea


subject: PUBCHEM.COMPOUND:3021749

object_name: quadriplegia


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM


subject: UNII:GR88G0I6UL


subject: UNII:GR88G0I6UL


subject: UNII:GR88G0I6UL


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:657309


subject: PUBCHEM.COMPOUND:657309


subject: PUBCHEM.COMPOUND:657309


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:177833

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:177833

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:177833

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:177833

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:177833

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:177833

object_name: childhood choroid plexus neoplasm


subject: CHEBI:177833

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:177833

object_name: pediatric infratentorial ependymoma


subject: CHEBI:177833

object_name: pediatric supratentorial ependymoma


subject: CHEBI:177833

object_name: Childhood Grade I Meningioma


subject: CHEBI:177833

object_name: childhood low-grade cerebellar astrocytoma


subject: CHEBI:177833

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:177833

object_name: Childhood Grade III Meningioma


subject: CHEBI:177833

object_name: Childhood Grade II Meningioma


subject: CHEBI:177833

object_name: childhood medulloepithelioma


subject: CHEBI:177833

object_name: Childhood Craniopharyngioma


subject: CHEBI:177833

object_name: childhood oligodendroglioma


subject: CHEBI:177833

object_name: pediatric cerebral ependymoblastoma


subject: CHEBI:177833

object_name: Childhood Mixed Glioma


subject: UMLS:C0764377

object_name: Recurrent Childhood Ependymoma


subject: UMLS:C0764377

object_name: Recurrent Childhood Brain Stem Glioma


subject: UMLS:C0764377

object_name: Recurrent Childhood Pineoblastoma


subject: UMLS:C0764377

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C0764377

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UMLS:C0764377

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C0764377

object_name: childhood choroid plexus neoplasm


subject: UMLS:C0764377

object_name: childhood central nervous system germ cell tumor


subject: UMLS:C0764377

object_name: pediatric infratentorial ependymoma


subject: UMLS:C0764377

object_name: pediatric supratentorial ependymoma


subject: UMLS:C0764377

object_name: Childhood Grade I Meningioma


subject: UMLS:C0764377

object_name: childhood low-grade cerebellar astrocytoma


subject: UMLS:C0764377

object_name: childhood low-grade cerebral astrocytoma


subject: UMLS:C0764377

object_name: Childhood Grade III Meningioma


subject: UMLS:C0764377

object_name: Childhood Grade II Meningioma


subject: UMLS:C0764377

object_name: childhood medulloepithelioma


subject: UMLS:C0764377

object_name: Childhood Craniopharyngioma


subject: UMLS:C0764377

object_name: childhood oligodendroglioma


subject: UMLS:C0764377

object_name: pediatric cerebral ependymoblastoma


subject: UMLS:C0764377

object_name: Childhood Mixed Glioma


subject: UNII:NU23Q531G1

subject_name: Catridecacog

object_name: ulcerative colitis


subject: UNII:NU23Q531G1

object_name: inflammatory bowel disease 1


subject: UNII:NU23Q531G1

object_name: Inflammation


subject: UNII:0661V34NTV

object_name: Alzheimer disease type 1


subject: UNII:0661V34NTV

object_name: Alzheimer disease


subject: CHEBI:31932

subject_name: olmesartan

object_name: Diabetes


subject: CHEBI:31932

object_name: diabetes mellitus


subject: CHEBI:31247

subject_name: Azelnidipine

object_name: type 2 diabetes mellitus


subject: CHEBI:31247


subject: CHEBI:31247


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Other abortion


subject: CHEBI:42797

object_name: Miscarriage


subject: CHEBI:42797

object_name: spontaneous abortion


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:95165

object_name: malignant soft tissue neoplasm


subject: CHEBI:95165

object_name: sarcoma


subject: CHEBI:95165

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:H52ITZ9X9D

subject_name: ACASUNLIMAB

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5417901

subject_name: BNT 311


subject: CHEBI:6931

subject_name: Midazolam

object_name: chronic kidney disease


subject: CHEBI:6931

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70752

subject_name: Dabigatran


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone


subject: PUBCHEM.COMPOUND:70105374


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: stroke disorder


subject: UMLS:C0728976

object_name: cerebrovascular disorder


subject: UMLS:C0728976

object_name: Stroke (heart beat)


subject: UMLS:C0728976

object_name: Stroke, CTCAE


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C0980837

subject_name: TRIGLYCERIDES,MEDIUM CHAIN OIL

object_name: long COVID-19


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Infection - perineal wound


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C2718754

subject_name: Ilaris

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Osteopenia


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:73629

subject_name: Phe-Asp-Cys


subject: CHEBI:73629

object_name: AIDS


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: pyoderma


subject: UMLS:C0003250

object_name: Dermatitis vegetans


subject: UMLS:C0003250

object_name: botryomycosis


subject: UMLS:C0003250

object_name: pyoderma gangrenosum


subject: UMLS:C0003250

object_name: Parastomal pyoderma gangrenosum


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: nasal cavity cancer


subject: CHEBI:4672

subject_name: Docetaxel

object_name: pharynx cancer


subject: CHEBI:4672

object_name: carcinoma of pharynx


subject: CHEBI:4672

object_name: nasal cavity carcinoma


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: UMLS:C0058773

subject_name: Diphtheria-Tetanus Vaccine

object_name: Recurrent Medulloblastoma


subject: UMLS:C0058773

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C0058773

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C5448047

subject_name: STP 705

object_name: basal cell carcinoma


subject: UMLS:C5448047

object_name: skin basal cell carcinoma


subject: CHEBI:7852

subject_name: Oxycodone

object_name: PREGNANCY UNDESIRED


subject: CHEBI:6931

subject_name: Midazolam


subject: UMLS:C5666951

subject_name: PCNA Inhibitor AOH1996

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5666951

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Consent Type - Hysterectomy


subject: CHEBI:60789

object_name: Ventral hernia


subject: CHEBI:3215

subject_name: Bupivacaine


subject: UMLS:C2983753

object_name: glioblastoma


subject: UMLS:C2983753

object_name: Brain Stem Glioblastoma


subject: UMLS:C2983753

object_name: glioma susceptibility 1


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: glioma


subject: UMLS:C3898831

object_name: malignant glioma


subject: UMLS:C2981617

subject_name: Clevidipine Butyrate Injectable Emulsion

object_name: subarachnoid hemorrhage


subject: UMLS:C2981617

object_name: hypertension


subject: UMLS:C2981617

object_name: Hypertension, CTCAE


subject: CHEBI:15040

subject_name: retinyl palmitate

object_name: HIV infection


subject: PUBCHEM.COMPOUND:39507

subject_name: Rimexolone

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:39507

object_name: Dry Eye, CTCAE


subject: PUBCHEM.COMPOUND:39507

object_name: Dryness of eye


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:231601

object_name: Stage IV Uterine Corpus Cancer


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: CHEBI:82960

subject_name: Raltegravir

object_name: relapsing-remitting multiple sclerosis


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: psoriasis


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: Chromosome Aberrations


subject: CHEBI:32588

object_name: chromosomal disorder


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Cannabis use disorder


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: malaria


subject: CHEMBL.COMPOUND:CHEMBL2103737

subject_name: HYDROXOCOBALAMIN

object_name: ulcerative colitis


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: inflammatory bowel disease 1


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: CHEBI:27786


subject: CHEBI:23359

subject_name: colchicine

object_name: essential hypertension


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Lumbar radiculopathy


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: UNII:A3ULP0F556

object_name: viral pneumonia


subject: UMLS:C3827085

object_name: adult lymphoma


subject: UMLS:C3827085

object_name: lymphoma


subject: UMLS:C3827085

object_name: pediatric lymphoma


subject: UMLS:C3827085

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3827085

object_name: non-Hodgkin lymphoma


subject: UMLS:C3827085

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3827085

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5207038

object_name: Adult Solid Neoplasm


subject: CHEBI:7465

object_name: psoriasis


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: abdominal aortic aneurysm


subject: UMLS:C3641690

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:231347

subject_name: Triapine

object_name: renal carcinoma


subject: CHEBI:231347

object_name: kidney neoplasm


subject: CHEBI:231347

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:11949633

subject_name: Co-codamol

object_name: toothache


subject: PUBCHEM.COMPOUND:11949633

object_name: Toothache, CTCAE


subject: UMLS:C2351132

subject_name: Acetaminophen / Codeine


subject: UMLS:C2351132


subject: UNII:CGA81G3KR5

subject_name: PUCOTENLIMAB

object_name: rectum adenocarcinoma


subject: UMLS:C5205493

subject_name: Pucotenlimab


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: interstitial lung disease 1


subject: CHEBI:6375

object_name: interstitial lung disease 2


subject: UMLS:C0960880

subject_name: angiotensin converting enzyme 2


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: ovarian cancer


subject: UMLS:C5237268

object_name: ovarian neoplasm


subject: UMLS:C5237268

object_name: ovarian carcinoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Severe Aplastic Anemia


subject: UNII:3A189DH42V

object_name: severe aplastic anemia


subject: CHEBI:174615

object_name: telomere syndrome


subject: CHEBI:174615

object_name: dyskeratosis congenita


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: PR:000022673

subject_name: antigen 43

object_name: Bone marrow depression


subject: PR:000022673

object_name: pancytopenia


subject: PR:000022673

object_name: Bone marrow hypocellularity


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673

object_name: Fanconi anemia


subject: PR:000022673

object_name: Fanconi anemia complementation group A


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:73612

subject_name: Met-Pro


subject: CHEBI:73612


subject: CHEBI:73612


subject: CHEBI:73612


subject: CHEBI:73612


subject: CHEBI:73612


subject: CHEBI:73612

object_name: Myelodysplasia


subject: CHEBI:73612


subject: CHEBI:73612


subject: CHEBI:73612


subject: UNII:BE9PTC7J7P

subject_name: MP


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: UNII:BE9PTC7J7P


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:97WKI06KTX

object_name: Childhood Breast Carcinoma


subject: UNII:97WKI06KTX

object_name: breast carcinoma


subject: UNII:97WKI06KTX

object_name: breast cancer


subject: CHEBI:66910

subject_name: Axitinib

object_name: salivary gland cancer


subject: CHEBI:29998

subject_name: D-serine residue

object_name: endogenous depression


subject: CHEBI:29998

object_name: major depressive disorder


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: UMLS:C1880218

subject_name: serine, D-


subject: UMLS:C1880218


subject: CHEBI:5132

subject_name: Flutamide

object_name: head and neck squamous cell carcinoma


subject: CHEBI:71954

subject_name: Buparlisib

object_name: breast neoplasm


subject: UMLS:C1450474

subject_name: Noscapine Hydrochloride

object_name: Plasma cell myeloma refractory


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids

object_name: alcohol abuse


subject: UMLS:C0032615

object_name: alcohol dependence


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:26208


subject: CHEBI:16822

subject_name: choline sulfate

object_name: alcoholic liver diseases


subject: CHEBI:15354

subject_name: Choline


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Surgical procedure finding


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: GTOPDB:13443

object_name: HER2-positive gastric cancer


subject: GTOPDB:13443

object_name: Gastroesophageal junction cancer


subject: UMLS:C5417907

subject_name: Anti-HER2 Monoclonal Antibody HLX22


subject: UMLS:C5417907


subject: UNII:7MPP85IIJ3

object_name: dedifferentiated liposarcoma


subject: UNII:7MPP85IIJ3

object_name: Childhood Synovial Sarcoma


subject: UNII:7MPP85IIJ3

object_name: Adult Synovial Sarcoma


subject: UNII:7MPP85IIJ3

object_name: synovial sarcoma


subject: UNII:7MPP85IIJ3

object_name: Ewing sarcoma


subject: UNII:7MPP85IIJ3

object_name: malignant soft tissue neoplasm


subject: UNII:7MPP85IIJ3

object_name: sarcoma


subject: CHEBI:5134

subject_name: Fluticasone

object_name: chronic rhinosinusitis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Pancreatic cancer non-resectable


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Breech presentation


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:25127414

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:25127414

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:25127414

object_name: Inflammatory carcinoma of breast stage IV


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: intestinal disorder


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:81579

object_name: childhood myelodysplastic syndrome


subject: CHEBI:81579

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5666919

subject_name: Anti-c-Met ADC ABBV-400

object_name: gastroesophageal adenocarcinoma


subject: UMLS:C5666919

object_name: colorectal cancer


subject: UMLS:C5666919

object_name: colorectal carcinoma


subject: UMLS:C5666919

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5666919

object_name: non-small cell lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:75179


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:149785

subject_name: nelociguat

object_name: impotence


subject: CHEBI:149785

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:149785

object_name: Erectile dysfunction


subject: CHEBI:31824

subject_name: Mesna

object_name: Implant Capsular Contracture


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UMLS:C5691128


subject: CHEBI:32599

object_name: premature birth (history)


subject: CHEBI:7565

subject_name: Nifedipine


subject: UNII:3T25U84H4U

subject_name: TELOTRISTAT ETIPRATE

object_name: QT interval


subject: UMLS:C2825840

subject_name: Xermelo


subject: PUBCHEM.COMPOUND:153997

subject_name: Zosuquidar Trihydrochloride

object_name: leukemia


subject: PUBCHEM.COMPOUND:153997

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:153997

object_name: Myelodysplasia


subject: UNII:813AGY3126

subject_name: zosuquidar trihydrochloride


subject: UNII:813AGY3126


subject: UNII:813AGY3126


subject: CHEBI:136040

subject_name: Levomilnacipran

object_name: nicotine dependence


subject: CHEBI:135005

subject_name: Milnacipran


subject: UMLS:C1832046

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: HER2 gene amplification


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C5784989

subject_name: HER2 Inhibitor ELVN-002


subject: UMLS:C5784989


subject: UMLS:C5784989


subject: UMLS:C5784989

object_name: HER2 positive breast carcinoma


subject: UMLS:C5784989

object_name: HER2-positive gastric cancer


subject: UMLS:C5784989


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: colorectal cancer


subject: CHEBI:231005

object_name: colorectal carcinoma


subject: CHEBI:231005

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: PR:000011357

subject_name: NPC intracellular cholesterol transporter 2

object_name: prostate carcinoma


subject: PR:000011357

object_name: prostate cancer


subject: UniProtKB:P03114

subject_name: VE1_HPV16 Replication protein E1 (sprot)


subject: UniProtKB:P03114


subject: CHEBI:28241

subject_name: Papaverine


subject: CHEBI:28241


subject: CHEBI:8081

subject_name: Phentolamine


subject: CHEBI:8081


subject: UMLS:C3890596

subject_name: Compound Kushen Injection

object_name: cervical cancer


subject: UMLS:C3890596

object_name: cervical carcinoma


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Fusion of spine (disease)


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Stage IIC Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041

object_name: prostate adenocarcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: end stage renal failure


subject: UMLS:C0521942

object_name: Chronic uremia


subject: UMLS:C1571394

object_name: Hepatic impairment


subject: CHEBI:94187

subject_name: Givinostat


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: acute myeloid leukemia


subject: CHEBI:75179

subject_name: Trifluridine

object_name: triple-negative breast carcinoma


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:231679

object_name: Recurrent Glioblastoma


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: periodontitis


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Functional constipation


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Sports Injury


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Stress Fracture


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Locally Advanced Urothelial Carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Unresectable Urothelial Carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: DRUGBANK:DB17518


subject: DRUGBANK:DB17518

object_name: Stomach cancer


subject: DRUGBANK:DB17518

object_name: gastric cancer


subject: CHEBI:8364

subject_name: Prazosin

object_name: sleep disorder, initiating and maintaining sleep


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:4911

subject_name: Etoposide

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: intraocular lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: noncutaneous extranodal lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: T-cell childhood acute lymphocytic leukemia


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:163203554

subject_name: Gemigliptin tartrate sesquihydrate

object_name: type 2 diabetes mellitus


subject: UNII:M34AEE9NG7

subject_name: GEMIGLIPTIN TARTRATE SESQUIHYDRATE


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin

object_name: Reactive hypoglycemia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: erythrocyte glutathione deficiency


subject: PUBCHEM.COMPOUND:10198924

subject_name: CHOLINE BITARTRATE

object_name: Fetal alcohol exposure


subject: PUBCHEM.COMPOUND:10198924

object_name: partial fetal alcohol syndrome


subject: PUBCHEM.COMPOUND:10198924

object_name: Alcohol Related Neurodevelopmental Disorder


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: Myocardial injury


subject: UNII:D652ZWF066

object_name: hypokalemia


subject: UNII:D652ZWF066

object_name: Hypokalemia, CTCAE


subject: CHEBI:9288

subject_name: Streptozocin


subject: CHEBI:9288


subject: CHEBI:9288


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2347619


subject: UMLS:C3896920

subject_name: MDM2/MDMX Inhibitor ALRN-6924

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C3896920

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:6801

subject_name: Metformin

object_name: primary progressive multiple sclerosis


subject: CHEBI:6801

object_name: secondary progressive multiple sclerosis


subject: UMLS:C1608327

subject_name: Instillagel

object_name: hemorrhoid


subject: UMLS:C1608327

object_name: Hemorrhoids, CTCAE 3.0


subject: UMLS:C1608327

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:52970

object_name: COVID-19 respiratory infection


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Postoperative delirium


subject: CHEBI:5103

object_name: Sedation


subject: CHEBI:5103

object_name: Sedated


subject: CHEBI:135738

subject_name: Clevidipine

object_name: intracranial vasospasm


subject: CHEBI:135738

object_name: brain aneurysm


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Memory Disorders


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: PR:000001379


subject: UMLS:C3530137

object_name: non-Hodgkin lymphoma


subject: UMLS:C3530137

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3530137

object_name: follicular lymphoma


subject: UMLS:C3530137

object_name: mantle cell lymphoma


subject: UMLS:C3530137

object_name: marginal zone lymphoma


subject: UMLS:C3530137

object_name: MALT lymphoma


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Depressed mood


subject: CHEBI:71200

object_name: Cancer patients and suicide and depression


subject: CHEBI:71200

object_name: Depressed - symptom


subject: CHEBI:71200

object_name: Depression, CTCAE


subject: CHEBI:71200

object_name: Inflammation


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:30145

subject_name: lithium atom

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:30145

object_name: amyotrophic lateral sclerosis


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: CHEBI:231350

subject_name: Pacritinib

object_name: VEXAS syndrome


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: outcomes general quality of life


subject: UNII:N824AOU5XV

object_name: Perceived quality of life


subject: UNII:N824AOU5XV

object_name: Good quality of life


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: rickets


subject: CHEBI:3311

object_name: Nutritional Rickets


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: severe acute respiratory syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:44661

subject_name: Olomoucine

object_name: COPD, severe early onset


subject: CHEBI:44661

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4742301

object_name: rheumatoid arthritis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Graft failure


subject: UNII:1H87NVF4DB

subject_name: GLUCAGON HYDROCHLORIDE

object_name: type 1 diabetes mellitus 1


subject: UNII:1H87NVF4DB

object_name: type 1 diabetes mellitus


subject: UNII:1H87NVF4DB

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:1H87NVF4DB

object_name: obesity


subject: UNII:1H87NVF4DB

object_name: Obesity, CTCAE


subject: CHEBI:4953

subject_name: Exemestane

object_name: sleep disorder


subject: CHEBI:4953

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:4953

object_name: Fatigue


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: CHEBI:63633


subject: UMLS:C4726564

subject_name: RV001 Vaccine

object_name: Prostate cancer recurrent


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: liver carcinoma


subject: DRUGBANK:DB15074

object_name: liver cancer


subject: DRUGBANK:DB15074

object_name: liver neoplasm


subject: DRUGBANK:DB15074

object_name: Adult Liver Carcinoma


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284


subject: CHEBI:465284


subject: CHEBI:465284


subject: DRUGBANK:DB14248

subject_name: Bos taurus gallstone

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:22833609

subject_name: Chitobiose


subject: CHEBI:17606

subject_name: Iodine

object_name: adrenal gland pheochromocytoma


subject: CHEBI:17606

object_name: pheochromocytoma


subject: CHEBI:17606

object_name: paraganglioma


subject: CHEMBL.COMPOUND:CHEMBL5095381

subject_name: RECATICIMAB

object_name: carcinoma of biliary tract


subject: UMLS:C5446789

subject_name: Recaticimab


subject: GTOPDB:13085

subject_name: adebrelimab


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: Renal rickets


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: GTOPDB:10492

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: GTOPDB:10492

object_name: gallbladder cancer


subject: GTOPDB:10492

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: GTOPDB:10492

object_name: Stage III Gallbladder Cancer AJCC v8


subject: GTOPDB:10492

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: GTOPDB:10492

object_name: gallbladder carcinoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen


subject: MESH:C508870


subject: MESH:C508870


subject: MESH:C508870


subject: MESH:C508870


subject: MESH:C508870


subject: MESH:C508870


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: small bowel bacterial overgrowth


subject: PUBCHEM.COMPOUND:46783403

object_name: stomach disease


subject: PUBCHEM.COMPOUND:46783403

object_name: digestive system disorder


subject: CHEBI:28851

subject_name: phenanthrene

object_name: Environmental Exposure


subject: CHEBI:28851

object_name: environmental exposure (history)


subject: CHEBI:41423

subject_name: Celecoxib

object_name: myocardial ischemia


subject: CHEBI:41423

object_name: Family history of ischemic heart disease


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: type 1 diabetes mellitus


subject: MESH:C575982

subject_name: docosahexaenoic acid monoacylglyceride

object_name: preterm premature rupture of the membranes


subject: CHEBI:50114

subject_name: estrogen

object_name: genetic disease


subject: PR:000036955

subject_name: V-type immunoglobulin domain-containing suppressor of T-cell activation

object_name: gingival recession


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Anorexia


subject: CHEBI:15365

subject_name: Aspirin

object_name: fallopian tube carcinoma


subject: CHEBI:15365

object_name: fallopian tube cancer


subject: CHEBI:15365

object_name: Fallopian tube infection


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Bone marrow transplant failure


subject: UMLS:C3274621

object_name: rheumatoid arthritis


subject: CHEBI:3395

subject_name: carbidopa

object_name: Irritable heart


subject: CHEBI:3395

object_name: neurocirculatory asthenia


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:80230

object_name: Stomach cancer


subject: CHEBI:80230

object_name: gastric cancer


subject: CHEBI:60004

subject_name: mixture

object_name: pneumonia


subject: CHEBI:60004

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0439962

subject_name: Mixture


subject: UMLS:C0439962


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib

object_name: HER2 positive breast carcinoma


subject: UMLS:C5854440

subject_name: Anti-CD33/CD123/CD70 DARPin CD3 Engager MP0533

object_name: acute graft versus host disease


subject: UMLS:C5854440

object_name: leukemia


subject: UMLS:C5854440

object_name: childhood leukemia


subject: UMLS:C1706415

subject_name: Interleukin-3 Receptor alpha Subunit


subject: UMLS:C1706415


subject: UMLS:C1706415


subject: PR:000001865

subject_name: interleukin-3 receptor class 2 alpha chain


subject: PR:000001865


subject: PR:000001865


subject: GTOPDB:5079


subject: GTOPDB:5079


subject: GTOPDB:5079


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:349552KRHK

subject_name: Simendan

object_name: subarachnoid hemorrhage


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: MESH:C041775

subject_name: Gelox

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: multiple sclerosis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3515


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Hodgkin Disease


subject: CHEBI:135918

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:135918

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Coxitis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: GTOPDB:4985

object_name: IgA vasculitis


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:8382

subject_name: Prednisone

object_name: acute graft vs. host disease


subject: CHEBI:8382

object_name: Adverse effects


subject: UMLS:C4521177

object_name: cognitive disorder


subject: CHEBI:42255

subject_name: Epigallocatechin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:42255

object_name: obesity


subject: CHEBI:42255

object_name: Obesity, CTCAE


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: syphilis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Relapsing acute myeloid leukemia


subject: UNII:XC0UT08SNJ

object_name: Refractory acute myeloid leukemia


subject: UNII:XC0UT08SNJ


subject: UNII:54T74394F8

subject_name: IADADEMSTAT


subject: UNII:54T74394F8


subject: MESH:C000730035

subject_name: iadademstat


subject: MESH:C000730035


subject: UMLS:C1176324

object_name: graft versus host disease


subject: CHEBI:15372

object_name: peripheral vascular disease


subject: CHEBI:15372

object_name: peripheral arterial disease


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E


subject: PUBCHEM.COMPOUND:5320784


subject: UMLS:C5418061

object_name: adult acute myeloid leukemia


subject: UMLS:C5418061

object_name: childhood acute myeloid leukemia


subject: UMLS:C5418061

object_name: acute myeloid leukemia


subject: UMLS:C5418061

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:72296

subject_name: Apixaban

object_name: essential thrombocythemia


subject: CHEBI:72296

object_name: JAK2 Gene Mutation


subject: CHEBI:72296

object_name: myelofibrosis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: morbid obesity


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: HPV-associated cervical carcinoma


subject: UNII:52CMI0WC3Y

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: DRUGBANK:DB17512


subject: DRUGBANK:DB17512


subject: UMLS:C0908244

subject_name: NXY 059

object_name: Acute Stroke


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea

object_name: Diabetes


subject: CHEBI:26831

object_name: hypoglycemia


subject: CHEBI:26831

object_name: Blood glucose below reference range (finding)


subject: CHEBI:26831

object_name: Hypoglycemia, CTCAE


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: CHEBI:6931

subject_name: Midazolam

object_name: Postoperative delirium


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Multiple Trauma


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C1313820

object_name: colorectal cancer


subject: UMLS:C1313820

object_name: colorectal carcinoma


subject: UMLS:C1313820

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:LSJ4493RPW

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Ascites


subject: PUBCHEM.COMPOUND:76322320

object_name: Ascites, CTCAE


subject: PUBCHEM.COMPOUND:76322320

object_name: Primary bacterial peritonitis


subject: PUBCHEM.COMPOUND:76322320

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: CHEBI:94807


subject: CHEBI:94807


subject: CHEBI:94807


subject: CHEBI:100246

subject_name: Norfloxacin


subject: CHEBI:100246


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: peptic esophagitis


subject: CHEBI:8768

object_name: Gastro-esophageal reflux disease with esophagitis


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: pterygium


subject: CHEBI:4031

object_name: conjunctival pterygium


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: leukemia


subject: CHEBI:17549

object_name: childhood leukemia


subject: CHEBI:17549

object_name: adult lymphoma


subject: CHEBI:17549

object_name: lymphoma


subject: CHEBI:17549

object_name: pediatric lymphoma


subject: UNII:J241Y80EEO

subject_name: Emraclidine

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Scarring of uterus


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: hematologic disorder


subject: UNII:4F4X42SYQ6

object_name: oncologic disorders


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: refractory malignant neoplasm


subject: UNII:KXG2PJ551I

object_name: Unresectable Carcinoma


subject: UNII:KXG2PJ551I

object_name: Recurrent Malignant Neoplasm


subject: UNII:KXG2PJ551I

object_name: Recurrent Carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Adult Solid Neoplasm


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:95060

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:95060

object_name: metastatic melanoma


subject: CHEBI:95060

object_name: stage IIIB melanoma


subject: CHEBI:95060

object_name: stage IIIC melanoma


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: alternating hemiplegia of childhood


subject: MESH:C542173

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C542173

object_name: obesity


subject: MESH:C542173

object_name: Obesity, CTCAE


subject: MESH:C542173

object_name: abdominal obesity-metabolic syndrome


subject: MESH:C542173

object_name: metabolic syndrome X


subject: MESH:C542173

object_name: inherited lipid metabolism disorder


subject: MESH:C542173

object_name: Dyslipidemia


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Non-small cell lung cancer stage III


subject: CHEBI:6427

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: atopic eczema


subject: UMLS:C0225326

subject_name: fiber


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Rotator cuff tear


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Drug action (disorder)


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UMLS:C1723114

object_name: epilepsy


subject: UMLS:C1723114

object_name: focal epilepsy


subject: UMLS:C1723114

object_name: temporal lobe epilepsy


subject: CHEBI:5390

subject_name: Glu-Glu

object_name: Premenstrual Dysphoric Disorder


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:31355

subject_name: Carboplatin

object_name: poisoning


subject: CHEBI:31355

object_name: sarcopenia


subject: UMLS:C5203433

subject_name: Golimumab Liquid Injection

object_name: ankylosing spondylitis


subject: UMLS:C5203433

object_name: Coxitis


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: UMLS:C4082792

subject_name: Béfizal

object_name: Safety Issues


subject: CHEBI:47612

subject_name: Bezafibrate


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: Parkinsonism


subject: CHEBI:78351

object_name: chorea


subject: CHEBI:78351

object_name: Ataxia


subject: CHEBI:78351

object_name: atactic disorder


subject: CHEBI:78351

object_name: Ataxia as late effect of cerebrovascular disease


subject: CHEBI:78351

object_name: Dyssynergia


subject: CHEBI:78351

object_name: Ataxia, CTCAE_5


subject: CHEBI:78351

object_name: dystonia


subject: CHEBI:78351

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:78351

object_name: Fatigue


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Mantle cell lymphoma stage I


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:28887

object_name: Mantle cell lymphoma stage III


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: UMLS:C2347652

subject_name: Povidone-Iodine Solution

object_name: White Spot Lesion


subject: CHEBI:6078

subject_name: Ivermectin

object_name: itch; scabies


subject: UMLS:C2729286

subject_name: Injection, docetaxel, 1 mg administered

object_name: Stomach cancer


subject: UMLS:C2729286

object_name: gastric cancer


subject: UMLS:C5203163

subject_name: Docetaxel Liquid Injection


subject: UMLS:C5203163


subject: UMLS:C0520158

subject_name: Injection, irinotecan, 20 mg administered


subject: UMLS:C0520158


subject: UMLS:C5206660

subject_name: Anbenitamab


subject: UMLS:C5206660


subject: CHEBI:91872

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:91872

object_name: Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:31824

subject_name: Mesna

object_name: Blast Phase


subject: CHEBI:31824

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:31824


subject: CHEBI:31824

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:52172


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450


subject: UMLS:C5203325

subject_name: Etomidate Liquid Injection

object_name: Sedation complication


subject: CHEBI:4910

subject_name: Etomidate


subject: CHEBI:58097

object_name: cardiovascular disorder


subject: CHEBI:17303

subject_name: Morphine


subject: GTOPDB:12989

subject_name: toripalimab

object_name: breast neoplasm


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:50634

object_name: sickle cell disease


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: asthma


subject: CHEBI:32300

subject_name: Voglibose

object_name: Non-insulin-dependent diabetes mellitus without complications


subject: CHEBI:6801

subject_name: Metformin


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:135449332

object_name: chronic leukemia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Adenocarcinoma of lung, stage IV


subject: UNII:28X28X9OKV

object_name: Metastatic Lung Large Cell Carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:75958

subject_name: solution

object_name: osteoarthritis susceptibility 6


subject: CHEBI:75958

object_name: osteoarthritis, knee


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Postoperative hematoma


subject: MESH:D017077

subject_name: Culture Media, Conditioned

object_name: Ischemic stroke


subject: UNII:N673F6W2VH

subject_name: Odanacatib

object_name: prostate carcinoma


subject: UNII:N673F6W2VH

object_name: prostate cancer


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: corneal edema


subject: CHEBI:74824

subject_name: Thr-Ala


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000016550


subject: CHEBI:24433

subject_name: group


subject: UMLS:C5417830

subject_name: Rilunermin Alfa

object_name: Malignant ascites


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: primary biliary cholangitis


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:3367


subject: UMLS:C3642443

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1568660

object_name: plasma cell myeloma


subject: UMLS:C1521807

object_name: Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Non-small cell lung cancer stage 0


subject: UMLS:C1521807

object_name: Non-small cell lung cancer stage I


subject: UMLS:C1521807

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1521807

object_name: Non-small cell lung cancer stage II


subject: UMLS:C1521807

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C1521807

object_name: Carcinoma of colon, stage I


subject: UMLS:C1521807

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage I Colon Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage II Colon Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage II Colon Cancer AJCC v7


subject: UMLS:C1521807

object_name: Stage II Colon Cancer


subject: UMLS:C1521807

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C1521807

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C1521807

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1521807

object_name: ovarian sarcoma


subject: UMLS:C1521807

object_name: Colon cancer recurrent


subject: UMLS:C1521807

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C1521807

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage III Colon Cancer


subject: UMLS:C1521807

object_name: malignant epithelial tumor of ovary


subject: UMLS:C1521807

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UMLS:C1521807

object_name: Stage I Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage II Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1521807

object_name: Ovarian germ cell cancer stage IV


subject: UMLS:C1521807

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1521807

object_name: Recurrent ovarian cancer


subject: UMLS:C1521807

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Ovarian epithelial cancer stage II


subject: UMLS:C1521807

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Ovarian cancer stage IV


subject: UMLS:C1521807

object_name: Ovarian cancer stage III


subject: UMLS:C1521807

object_name: appendix carcinoma


subject: UMLS:C1521807

object_name: fallopian tube carcinoma


subject: UMLS:C1521807

object_name: fallopian tube cancer


subject: UMLS:C1521807

object_name: Plexosarcoma


subject: UMLS:C1521807

object_name: Small intestine carcinoma recurrent


subject: UMLS:C1521807

object_name: recurrent gastric cancer


subject: UMLS:C1521807

object_name: Malignant neoplasm of stomach stage I


subject: UMLS:C1521807

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C1521807

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C1521807

object_name: Malignant neoplasm of stomach stage II


subject: UMLS:C1521807

object_name: Recurrent Rectal Cancer


subject: UMLS:C1521807

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C1521807

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C1521807

object_name: Rectal cancer stage I


subject: UMLS:C1521807

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage I Rectal Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C1521807

object_name: Rectal cancer stage IV


subject: UMLS:C1521807

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C1521807

object_name: Stage II Rectal Cancer AJCC v7


subject: UMLS:C1521807

object_name: Stage II Rectal Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage II Rectal Cancer


subject: UMLS:C1521807

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C1521807

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1521807

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1521807

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C1521807

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C1521807

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C1521807

object_name: Localized Resectable Adult Liver Carcinoma


subject: UMLS:C1521807

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C1521807

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C1521807

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C1521807

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1521807

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C1521807

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1521807

object_name: Localized Extrahepatic Bile Duct Carcinoma


subject: UMLS:C1521807

object_name: advanced adult primary liver cancer


subject: UMLS:C1521807

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C1521807

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Pancreatic carcinoma stage I


subject: UMLS:C1521807

object_name: Stage I Pancreatic Cancer AJCC v8


subject: UMLS:C1521807

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1521807

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C1521807

object_name: Localized Digestive System Neuroendocrine Tumor G1


subject: UMLS:C1521807

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: stage IV pancreatic cancer


subject: UMLS:C1521807

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Pancreatic carcinoma stage II


subject: UMLS:C1521807

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C1521807

object_name: Pancreatic carcinoma stage III


subject: UMLS:C1521807

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: gallbladder cancer


subject: UMLS:C1521807

object_name: Localized Gallbladder Carcinoma


subject: UMLS:C1521807

object_name: peritoneum cancer


subject: UMLS:C1521807

object_name: small intestine leiomyosarcoma


subject: UMLS:C1521807

object_name: small intestine adenocarcinoma


subject: UMLS:C1521807

object_name: small intestine lymphoma


subject: UMLS:C1521807

object_name: Recurrent Uterine Sarcoma


subject: UMLS:C1521807

object_name: Stage III Uterine Sarcoma AJCC v7


subject: UMLS:C1521807

object_name: Stage II Uterine Sarcoma AJCC v7


subject: UMLS:C1521807

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: UMLS:C1521807

object_name: Stage I Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

subject_name: Motexafin lutetium

object_name: Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer stage 0


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer stage I


subject: PUBCHEM.COMPOUND:3081907

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer stage II


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer stage IIIA


subject: PUBCHEM.COMPOUND:3081907

object_name: Non-small cell lung cancer stage IIIB


subject: PUBCHEM.COMPOUND:3081907

object_name: Carcinoma of colon, stage I


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Colon Cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Colon Cancer AJCC v6


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of colon stage IV


subject: PUBCHEM.COMPOUND:3081907

object_name: ovarian sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Colon Cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Ovarian Germ Cell Tumor


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Ovarian germ cell cancer stage IV


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Ovarian epithelial cancer stage II


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:3081907

object_name: Ovarian cancer stage III


subject: PUBCHEM.COMPOUND:3081907

object_name: appendix carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: fallopian tube carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: fallopian tube cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Small intestine carcinoma recurrent


subject: PUBCHEM.COMPOUND:3081907

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of stomach stage I


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of stomach stage II


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: stage I adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of stomach stage III


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: stage II adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: stage III adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Rectal cancer stage I


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Rectal cancer stage IV


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Rectal Cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:3081907

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Cancer of Gallbladder


subject: PUBCHEM.COMPOUND:3081907

object_name: Malignant neoplasm of gallbladder recurrent


subject: PUBCHEM.COMPOUND:3081907

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Localized Resectable Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:3081907

object_name: Unresectable Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:3081907

object_name: Localized Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Pancreatic carcinoma stage I


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:3081907

object_name: metastatic gastrointestinal carcinoid tumor


subject: PUBCHEM.COMPOUND:3081907

object_name: Localized Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Pancreatic carcinoma stage II


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3081907

object_name: Pancreatic carcinoma stage III


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3081907

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: Localized Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:3081907

object_name: small intestine leiomyosarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: small intestine adenocarcinoma


subject: PUBCHEM.COMPOUND:3081907

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Recurrent Uterine Sarcoma


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage III Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage II Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:3081907

object_name: Stage I Uterine Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer stage 0


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer stage I


subject: UNII:0V38NF6N89

object_name: Metastatic non-small cell lung cancer


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer stage II


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer recurrent


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:0V38NF6N89

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:0V38NF6N89

object_name: Carcinoma of colon, stage I


subject: UNII:0V38NF6N89

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Stage I Colon Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage II Colon Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage II Colon Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage II Colon Cancer


subject: UNII:0V38NF6N89

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:0V38NF6N89

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of colon stage IV


subject: UNII:0V38NF6N89

object_name: ovarian sarcoma


subject: UNII:0V38NF6N89

object_name: Colon cancer recurrent


subject: UNII:0V38NF6N89

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage III Colon Cancer


subject: UNII:0V38NF6N89

object_name: malignant epithelial tumor of ovary


subject: UNII:0V38NF6N89

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UNII:0V38NF6N89

object_name: Stage I Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Stage II Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Ovarian germ cell cancer stage IV


subject: UNII:0V38NF6N89

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Recurrent ovarian cancer


subject: UNII:0V38NF6N89

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Ovarian epithelial cancer stage II


subject: UNII:0V38NF6N89

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Ovarian cancer stage IV


subject: UNII:0V38NF6N89

object_name: Ovarian cancer stage III


subject: UNII:0V38NF6N89

object_name: appendix carcinoma


subject: UNII:0V38NF6N89

object_name: fallopian tube carcinoma


subject: UNII:0V38NF6N89

object_name: fallopian tube cancer


subject: UNII:0V38NF6N89

object_name: Plexosarcoma


subject: UNII:0V38NF6N89

object_name: Small intestine carcinoma recurrent


subject: UNII:0V38NF6N89

object_name: recurrent gastric cancer


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of stomach stage I


subject: UNII:0V38NF6N89

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of stomach stage II


subject: UNII:0V38NF6N89

object_name: Recurrent Rectal Cancer


subject: UNII:0V38NF6N89

object_name: stage I adult soft tissue sarcoma


subject: UNII:0V38NF6N89

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of stomach stage III


subject: UNII:0V38NF6N89

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: stage II adult soft tissue sarcoma


subject: UNII:0V38NF6N89

object_name: Stage IV adult soft tissue sarcoma


subject: UNII:0V38NF6N89

object_name: stage III adult soft tissue sarcoma


subject: UNII:0V38NF6N89

object_name: Rectal cancer stage I


subject: UNII:0V38NF6N89

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Stage I Rectal Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Rectal cancer stage IV


subject: UNII:0V38NF6N89

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:0V38NF6N89

object_name: Stage II Rectal Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage II Rectal Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage II Rectal Cancer


subject: UNII:0V38NF6N89

object_name: Pancreatic carcinoma recurrent


subject: UNII:0V38NF6N89

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UNII:0V38NF6N89

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:0V38NF6N89

object_name: Recurrent Cancer of Gallbladder


subject: UNII:0V38NF6N89

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:0V38NF6N89

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UNII:0V38NF6N89

object_name: Localized Resectable Adult Liver Carcinoma


subject: UNII:0V38NF6N89

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:0V38NF6N89

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UNII:0V38NF6N89

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:0V38NF6N89

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: UNII:0V38NF6N89

object_name: Localized Extrahepatic Bile Duct Carcinoma


subject: UNII:0V38NF6N89

object_name: advanced adult primary liver cancer


subject: UNII:0V38NF6N89

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:0V38NF6N89

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Pancreatic carcinoma stage I


subject: UNII:0V38NF6N89

object_name: Stage I Pancreatic Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UNII:0V38NF6N89

object_name: metastatic gastrointestinal carcinoid tumor


subject: UNII:0V38NF6N89

object_name: Localized Digestive System Neuroendocrine Tumor G1


subject: UNII:0V38NF6N89

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: stage IV pancreatic cancer


subject: UNII:0V38NF6N89

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: Pancreatic carcinoma stage II


subject: UNII:0V38NF6N89

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:0V38NF6N89

object_name: Pancreatic carcinoma stage III


subject: UNII:0V38NF6N89

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:0V38NF6N89

object_name: gallbladder cancer


subject: UNII:0V38NF6N89

object_name: Localized Gallbladder Carcinoma


subject: UNII:0V38NF6N89

object_name: peritoneum cancer


subject: UNII:0V38NF6N89

object_name: small intestine leiomyosarcoma


subject: UNII:0V38NF6N89

object_name: small intestine adenocarcinoma


subject: UNII:0V38NF6N89

object_name: small intestine lymphoma


subject: UNII:0V38NF6N89

object_name: Recurrent Uterine Sarcoma


subject: UNII:0V38NF6N89

object_name: Stage III Uterine Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage II Uterine Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: UNII:0V38NF6N89

object_name: Stage I Uterine Sarcoma AJCC v7


subject: UNII:1H7RSQ28BJ

subject_name: Ibodutant

object_name: irritable bowel syndrome


subject: UMLS:C3180273

subject_name: ibodutant


subject: UMLS:C3189458

subject_name: Betamethasone Valerate Cream

object_name: Early radiation dermatitis


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: UNII:YI437801BE

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: UNII:YI437801BE

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: UNII:YI437801BE

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: UNII:YI437801BE

object_name: folliculotropic mycosis fungoides


subject: UNII:YI437801BE

object_name: Transformed Mycosis Fungoides


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: CHEBI:51137

subject_name: Mianserin

object_name: post-traumatic stress disorder


subject: CHEBI:135883

subject_name: Canfosfamide

object_name: breast neoplasm


subject: UMLS:C1258106

subject_name: TLK 286


subject: CHEBI:4445

subject_name: Desflurane

object_name: Mechanical ventilation complication


subject: UNII:721809WQCP

subject_name: Ruboxistaurin

object_name: diabetic neuropathy


subject: PUBCHEM.COMPOUND:6438809

subject_name: Deanxit

object_name: Antidepressant discontinuation syndrome


subject: PUBCHEM.COMPOUND:6438809

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:6438809

object_name: Dyspepsia, CTCAE


subject: PUBCHEM.COMPOUND:6438809

object_name: Antidepressant drug adverse reaction


subject: PUBCHEM.COMPOUND:6438809

object_name: functional gastric disease


subject: UMLS:C0057220


subject: UMLS:C0057220


subject: UMLS:C0057220


subject: UMLS:C0057220


subject: UMLS:C0057220


subject: UMLS:C2606889

subject_name: AEGR 733

object_name: Hypercholesterolemia


subject: CHEBI:72297

subject_name: Lomitapide


subject: CHEBI:6121

subject_name: Ketamine

object_name: Breastfeeding (mother)


subject: CHEBI:6121

object_name: Drug action (disorder)


subject: CHEBI:6121

object_name: Labor Pain


subject: CHEBI:6121

object_name: Obstetric anesthesia problems


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: anxiety


subject: UMLS:C0013227

object_name: Anxiety symptoms


subject: UMLS:C0013227

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C0013227

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: traumatic encephalopathy


subject: CHEBI:4806

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:164726578

subject_name: daraxonrasib

object_name: Matthew-Wood syndrome


subject: PUBCHEM.COMPOUND:164726578

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:164726578

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:164726578

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:164726578

object_name: malignant pancreatic neoplasm


subject: UNII:B6T47Y2UAP

subject_name: DARAXONRASIB


subject: UNII:B6T47Y2UAP


subject: UNII:B6T47Y2UAP


subject: UNII:B6T47Y2UAP


subject: UNII:B6T47Y2UAP


subject: CHEBI:49166

subject_name: fluorodopa F 18

object_name: brain glioma


subject: CHEBI:49166

object_name: Intracranial glioma


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Infection


subject: PUBCHEM.COMPOUND:435949

object_name: Infection of musculoskeletal system


subject: PUBCHEM.COMPOUND:435949

object_name: Fractures, Ununited


subject: PUBCHEM.COMPOUND:435949

object_name: Bone fracture


subject: PUBCHEM.COMPOUND:435949

object_name: Fracture, CTCAE


subject: PUBCHEM.COMPOUND:435949

object_name: Infection and inflammatory reaction due to internal fixation device [any site]


subject: PUBCHEM.COMPOUND:435949

object_name: Wound Infection


subject: PUBCHEM.COMPOUND:435949

object_name: antibiotic side-effect


subject: PUBCHEM.COMPOUND:435949

object_name: Leg Injuries


subject: PUBCHEM.COMPOUND:435949

object_name: Fractured lower leg


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708


subject: UMLS:C3540708

object_name: Amputated structure (morphologic abnormality)


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Postoperative ileus


subject: CHEBI:38070

subject_name: anti-arrhythmia drug

object_name: heart disorder


subject: CHEBI:38070

object_name: Arrhythmia


subject: CHEBI:38070

object_name: coronary artery disorder


subject: CHEBI:38070

object_name: cardiac conduction defect


subject: CHEBI:38070

object_name: ventricular tachycardia


subject: CHEBI:38070

object_name: cardiovascular disorder


subject: CHEBI:38070

object_name: myocardial ischemia


subject: CHEBI:38070

object_name: coronary atherosclerosis


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents


subject: UMLS:C0003195


subject: UMLS:C0003195


subject: UMLS:C0003195


subject: UMLS:C0003195


subject: UMLS:C0003195


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage III renal cell cancer


subject: CHEBI:85990

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:85990

object_name: Renal cell carcinoma recurrent


subject: CHEBI:85990

object_name: Renal cancer recurrent


subject: CHEBI:85990

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:85990

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: GTOPDB:2943

subject_name: secretin

object_name: Intraductal papillary mucinous neoplasm


subject: GTOPDB:2943

object_name: exocrine pancreatic carcinoma


subject: CHEBI:232390


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: cervical cancer


subject: CHEBI:64321

object_name: cervical carcinoma


subject: CHEBI:64321

object_name: nasopharyngeal carcinoma


subject: CHEBI:64321

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:64321

object_name: malignant tumor of nasopharynx


subject: CHEBI:64321

object_name: Radiation-induced nausea and vomiting


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Second or third degree burns


subject: CHEBI:2942

subject_name: Azadirachtin

object_name: Chronic anal fissure


subject: CHEBI:38473

subject_name: azadirachtin


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE


subject: GTOPDB:7055

subject_name: sucralfate


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: cerebral palsy


subject: CHEBI:6504

object_name: multiple sclerosis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Other chronic postoperative pain


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C5392354

object_name: Autoimmunity


subject: MESH:D064209

subject_name: Phytochemicals

object_name: nicotine dependence


subject: CHEBI:4445

subject_name: Desflurane

object_name: Lung Injury


subject: CHEBI:9130


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: CHEBI:50847

object_name: ovarian cancer


subject: CHEBI:50847

object_name: ovarian neoplasm


subject: CHEBI:50847

object_name: ovarian carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: skin melanoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:229213

subject_name: Elacestrant

object_name: endometrial cancer


subject: CHEBI:229213

object_name: uterine corpus cancer


subject: CHEBI:229213

object_name: endometrial carcinoma


subject: UMLS:C1134664

object_name: cancer


subject: UMLS:C1134664

object_name: neoplasm


subject: UMLS:C1134664

object_name: childhood neoplasm


subject: UMLS:C1134664

object_name: neoplastic syndrome


subject: UMLS:C1134664

object_name: cancer or benign tumor


subject: MESH:C477385

subject_name: montanide ISA 51


subject: MESH:C477385


subject: MESH:C477385


subject: MESH:C477385


subject: MESH:C477385


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Neuroses, Anxiety


subject: CHEBI:3757

subject_name: Clonidine

object_name: Umbilical hernia


subject: PUBCHEM.COMPOUND:2269

object_name: childhood asthma with acute exacerbation


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Status epilepticus


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: alcohol abuse


subject: UNII:0K5743G68X

object_name: alcohol dependence


subject: UNII:7DT29059VX

object_name: HER2 positive breast carcinoma


subject: UNII:J27WDC343N

subject_name: MESOTHELIN

object_name: Adult Solid Neoplasm


subject: UNII:J27WDC343N

object_name: liver cancer


subject: UNII:J27WDC343N

object_name: liver neoplasm


subject: UNII:J27WDC343N

object_name: Adult Liver Carcinoma


subject: UNII:J27WDC343N

object_name: liver carcinoma


subject: UNII:J27WDC343N

object_name: Childhood Breast Carcinoma


subject: UNII:J27WDC343N

object_name: breast carcinoma


subject: UNII:J27WDC343N

object_name: breast cancer


subject: UNII:J27WDC343N

object_name: brain neoplasm


subject: UNII:J27WDC343N

object_name: colorectal carcinoma


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Diabetic peripheral neuropathy


subject: CHEBI:233446

subject_name: suzetrigine


subject: PUBCHEM.COMPOUND:122549964

object_name: chronic hepatitis B virus infection


subject: UMLS:C4722296

subject_name: Small Interfering RNA [EPC]


subject: UMLS:C1815405

subject_name: Strepsils Anaesthetic Formula

object_name: pharyngitis


subject: UMLS:C1815405

object_name: Pharyngalgia


subject: UMLS:C1815405

object_name: Sore Throat, CTCAE


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: carcinoma


subject: UMLS:C0796512

subject_name: CCI 779

object_name: adult lymphoma


subject: UMLS:C0796512

object_name: lymphoma


subject: UMLS:C0796512

object_name: pediatric lymphoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Peritoneal adhesion


subject: UMLS:C5445196

subject_name: Oxaliplatin Liquid Injection


subject: UMLS:C5206815


subject: PR:000004140

subject_name: apolipoprotein A-I

object_name: acute coronary syndrome


subject: UMLS:C0260264

subject_name: steroid drugs

object_name: type 2 diabetes mellitus


subject: UMLS:C0260264

object_name: Diabetes


subject: UMLS:C0260264

object_name: diabetes mellitus


subject: UMLS:C3827102

subject_name: PSMA-targeting Fluorescent Imaging Agent MDX1201-A488

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C3827102

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C3827102

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C3827102

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C3827102

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C3827102

object_name: Stage IIB Prostate Cancer AJCC v7